Skip to main content
SpringerLink
Log in

Abuse of Anabolic Androgenic Steroids (AAS) for Doping

  • Chapter
  • First Online:
Andrology

  • 568 Accesses

Abstract

Anabolic androgenic steroids (AAS) are the preferred drugs used in competitive and recreational sports and by bodybuilders to improve appearance and performance (Appearance and Performance-Enhancing Drugs, APED), commonly known as doping. Many AAS, often obtained via the Internet and from dubious sources, are not properly tested, and are consumed in extremely high doses and in irrational combinations with other drugs. Controlled clinical trials examining adverse effects are lacking because ethical restrictions prevent study subjects from being exposed to potentially toxic therapies, obscuring a causal relationship between AAS abuse and potential consequences. This chapter summarizes the side effects of AAS abuse, particularly the impact on reproductive system functions, based on detailed case reports and small clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Achar S, Rostamian A, Narayan SM (2010) Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. Am J Cardiol 106:893–901

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ackerman CM, Lowe LP, Lee H, Hayes MG, Dyer AR, Metzger BE et al (2012) Hapo study cooperative research group. Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat. J Androl 33:210–215

    CAS  PubMed  Google Scholar 

  • Alizade E, Avcı A, Fidan S, Tabakçı M, Bulut M, Zehir R et al (2015) The effect of chronic a nabolic-androgenic steroid use on Tp-E interval, Tp-E/Qt ratio, and Tp-E/Qtc ratio in male bodybuilders. Ann Noninvasive Electrocardiol 20(6):592–600

    PubMed  PubMed Central  Google Scholar 

  • Babigian A, Silverman RT (2001) Management of gynecomastia due to use of anabolic steroids in bodybuilders. Plast Reconstr Surg 1:240–242

    Google Scholar 

  • Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG Jr (2017) Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation 135(21):1991–2002

    CAS  PubMed  PubMed Central  Google Scholar 

  • Baker J (1999) A report on alterations to the speaking and singing voices of four women following hormonal therapy with virilizing agents. J Voice 13:496–507

    CAS  PubMed  Google Scholar 

  • Barbosa Neto O, da Mota GR, De Sordi CC, EAMR R, LAPR R, Vieira da Silva MA et al (2018) Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities. Clin Auton Res 28(2):231–244

    PubMed  Google Scholar 

  • Basaria S (2010) Androgen abuse in athletes: detection and consequences. J Clin Endocrinol Metab 95:1533–1543

    CAS  PubMed  Google Scholar 

  • Baumann S, Jabbour C, Huseynov A, Borggrefe M, Haghi D, Papavassiliu T (2014) Myocardial scar detected by cardiovascular magnetic resonance in a competitive bodybuilder with longstanding abuse of anabolic steroids. Asian J Sports Med 5:e24058

    PubMed  PubMed Central  Google Scholar 

  • Bermon S, Garnier PY (2017) Serum androgen levels and their relation to performance in track and field: mass spectrometry results from 2127 observations in male and female elite athletes. Br J Sports Med 51(17):1309–1314

    PubMed  Google Scholar 

  • Bhasin S, Ravi J, Serra C, Singh R, Storer TW, Guo W et al (2012) Androgen effects on the skeletal muscle. In: Nieschlag E, Behre HM (eds) Testosterone: action, deficiency, substitution. Cambridge University Press, Cambridge, pp 191–206

    Google Scholar 

  • Björk T, Skåberg K, Engström I (2013) Eating disorders and anabolic androgenic steroids in males—similarities and differences in self-image and psychiatric symptoms. Subst Abuse Treat Prev Policy 8:1–7

    Google Scholar 

  • Blank C, Schobersberger W, Leichtfried V, Duschek S (2016) Health psychological constructs as predictors of doping susceptibility in adolescent athletes. Asian J Sports Med 7(4):e35024

    PubMed  PubMed Central  Google Scholar 

  • Blashill AJ, Safren SA (2014) Sexual orientation and anabolic-androgenic steroids in U.S. adolescent boys. Pediatrics 133:469–475

    PubMed  PubMed Central  Google Scholar 

  • Brennan BP, Kanayama G, Pope HG Jr (2013) Performance-enhancing drugs on the web: a growing public-health issue. Am J Addict 22:158–161

    PubMed  PubMed Central  Google Scholar 

  • Caso P, D’Andrea A, Caso I, Severino S, Calabrò P, Allocca F, Mininni N, Calabrò R (2006) The athlete’s heart and hypertrophic cardiomyopathy: two conditions which may be misdiagnosed and coexistent. Which parameters should be analysed to distinguish one disease from the other? J Cardiovasc Med (Hagerstown) 7:257–266

    PubMed  Google Scholar 

  • Cheung AS, Grossmann M (2018) Physiological basis behind ergogenic effects of anabolic androgens. Mol Cell Endocrinol 464:14–20

    CAS  PubMed  Google Scholar 

  • Clark BM, Schofield RS (2005) Dilated cardiomyopathy and acute liver injury associated with combined use of ephedra, gamma-hydroxybutyrate and anabolic steroids. Pharmacotherapy 25:756–761

    PubMed  Google Scholar 

  • De Ronde W, Smit D (2020) Anabolic androgenic steroid abuse in young males. Endocr Connect 4:102–111

    Google Scholar 

  • Deshmukh N, Petroczi A, Barker J, Szekely AD, Hussain I, Naughton DP (2010) Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids. Subst Abuse Treat Prev Policy 5:1–7

    Google Scholar 

  • Deuster D, Matulat P, Knief A, Zitzmann M, Rosslau K, Szukaj M, am Zehnhoff-Dinnesen A, Schmidt CM (2016) Voice deepening under testosterone treatment in female-to-male gender dysphoric individuals. Eur Arch Otorhinolaryngol 273(4):959–965

    PubMed  Google Scholar 

  • Di Bello V, Giorgi D, Bianchi M, Bertini A, Caputo MT, Valenti G, Furioso O, Alessandri L, Paterni M, Giusti C (1999) Effects of anabolic-androgenic steroids on weight-lifters’ myocardium: an ultrasonic videodensitometric study. Med Sci Sports Exerc 31:514–521

    PubMed  Google Scholar 

  • Dickerman RD, Schaller F, Prather I, McConahy WJ (1995) Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86:172–173

    CAS  PubMed  Google Scholar 

  • Dickerman RD, Shaller F, McConathy WJ (1998) Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid use. Cardiology 90:145–148

    CAS  PubMed  Google Scholar 

  • Dodge T, Hoagland MF (2010) The use of anabolic androgenic steroids and polypharmacy: a review of the literature. Drug Alcohol Depend 114:100–109

    Google Scholar 

  • Egner IM, Bruusgaard JC, Eftestøl E, Gundersen K (2013) A cellular memory mechanism aids overload hypertrophy in muscle long after an episodic exposure to anabolic steroids. J Physiol 591:6221–6230

    CAS  PubMed  PubMed Central  Google Scholar 

  • El Sherrif Y, Potts JR, Howard MR, Barnardo A, Cairns S, Knisely AS et al (2013) Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations? Liver Int 33:1266–1270

    PubMed  Google Scholar 

  • Evans NA (1997) Gym and tonic: a profile of 100 male steroid users. Br J Sports Med 31:54–58

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ferriman D, Gallwey JD (1961) Clinical assessment of body hair in women. J Clin Endocrinol Metab 21:1440–1447

    CAS  PubMed  Google Scholar 

  • Fineschi V, Baroldi G, Monciotti F, Paglicci Reattelli L, Turillazi E (2001) Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med 125:253–255

    CAS  PubMed  Google Scholar 

  • Franke WW, Berendonk B (1997) Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 43:1262–1279

    CAS  PubMed  Google Scholar 

  • Froehner M, Fischer R, Leike S, Hakenberg OW, Noack B, Wirth MP (1999) Intratesticular leiomyosarcoma in a young man after high-dose doping with oral-turinabol. Cancer 86:1571–1575

    CAS  PubMed  Google Scholar 

  • Fronczak CM, Kim ED, Barqawi AB (2012) The insults of illicit drug use on male fertility. J Androl 33(4):515–528

    CAS  PubMed  Google Scholar 

  • Gerber PA, Kukova G, Meller S, Neumann NJ, Homey B (2008) The dire consequences of doping. Lancet 372:656

    PubMed  Google Scholar 

  • Geyer H, Parr MK, Koehler K, Mareck U, Schänzer W, Thevis M (2008) Nutritional supplements cross-contaminated and faked with doping substances. J Mass Spectrom 43:892–902

    CAS  PubMed  Google Scholar 

  • Giannitrapani L, Soresi M, La Spada E, Cervello M, D’Alessandro N, Montalto G (2000) Sex hormones and risk of liver tumor. Ann N Y Acad Sci 1089:228–236

    Google Scholar 

  • Giannitrapani L, Soresi M, La Spada E, Cervello M, D’Alessandro N, Montalto G (2006) Sex hormones and risk of liver tumor. Ann N Y Acad Sci. 1089:228–36. https://doi.org/10.1196/annals.1386.044. PMID: 17261770.

  • Handelsman DJ (2020) Performance-enhancing hormone doping in sport. In: Feingold KJ, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland J, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP (eds) Endotext. MDText, South Dartmouth, MA

    Google Scholar 

  • Hartgens F, Rietjens G, Keizer HA, Kuipers H, Wolffenbuttel BH (2004) Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sports Med 38:253–259

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hero M, Wickman S, Hanhijärvi R, Siimes MA, Dunkel L (2005) Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen. J Pediatr 146:245–252

    CAS  PubMed  Google Scholar 

  • Inamdar Doddamani LS, Jayamma Y (2012) Acceleration of neutrophil precursors' maturation and immunostimulation of CD3+, CD4+ lymphocytes by stanozolol in mice. J Steroid Biochem Mol Biol 129(3–5):172–178

    PubMed  Google Scholar 

  • Kahn NN, Sinha AK, Spungen AM, Bauman WA (2006) Effects of oxandrolone, an anabolic steroid, on hemostasis. Am J Hematol 81:95–100

    CAS  PubMed  Google Scholar 

  • Kanayama G, Pope HG Jr (2018) History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol 464:4–13

    CAS  PubMed  Google Scholar 

  • Kindermann W (2006) Kardiovaskuläre Nebenwirkungen von anabol-androgenen Steroiden. Herz 31:566–573

    PubMed  Google Scholar 

  • Kistler L (2006) Todesfälle bei Anabolikamissbrauch. Todesursache, Befunde und rechtsmedizinische Aspekte. Dissertation zum Erwerb des Doktorgrades der Medizin an der medizinischen Fakultät der Ludwig-Maximilians-Universität zu München

    Google Scholar 

  • Knuth UA, Maniera H, Nieschlag E (1989) Anabolic steroids and semen parameters in bodybuilders. Fertil Steril 52:1041–1047

    CAS  PubMed  Google Scholar 

  • Krug O, Thomas A, Walpurgis K, Piper T, Sigmund G, Schänzer W, Laussmann T, Thevis M (2014) Identification of black market products and potential doping agents in Germany 2010–2013. Eur J Clin Pharmacol 70:1303–1311

    PubMed  Google Scholar 

  • Lemcke B, Zentgraf J, Behre HM, Kliesch S, Bramswig JH, Nieschlag E (1996) Long-term effects on testicular function of high-dose testosterone treatment for excessively tall stature. J Clin Endocrinol Metab 81:296–301

    CAS  PubMed  Google Scholar 

  • Lindén Hirschberg A, Elings Knutsson J, Helge T, Godhe M, Ekblom M, Bermon S, Ekblom B (2020) Effects of moderately increased testosterone concentration on physical performance in young women: a double blind, randomised, placebo controlled study. Br J Sports Med 54(10):599–604

    Google Scholar 

  • Lindqvist AS, Moberg T, Eriksson BO, Ehrnborg C, Rosén T, Fahlke C (2013) A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health. Br J Sports Med 47:965–969

    CAS  PubMed  Google Scholar 

  • Lippi G, Banfi G (2011) Doping and thrombosis in sports. Semin Thromb Hemost 37:918–928

    CAS  PubMed  Google Scholar 

  • Luijkx T, Velthuis BK, Backx FJG, Buckens CFM, Prakken NHJ, Rienks R, Mali WPTM, Cramer MJ (2013) Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes. Int J Cardiol 167:664–668

    PubMed  Google Scholar 

  • Lundholm L, Frisell T, Lichtenstein P, Långström N (2015) Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10,365 general population men. Addiction 110:100–108

    PubMed  Google Scholar 

  • Maisch B, Richter A, Sandmöller A, Porting I, Pankuweit S (2005) Inflammatory dilated cardiomyopathy (DCMI). Herz 30:535–544

    PubMed  Google Scholar 

  • Makarychev A, Medvedev S (2019) Doped and disclosed anatomopolitics, biopower, and sovereignty in the Russian sports industry. Politics Life Sci 38:132–143

    PubMed  Google Scholar 

  • Maron BJ, Haas TS, Ahluwalia A, Murphy CJ, Garberich RF (2016) Demographics and epidemiology of sudden death in young competitive athletes: from the United States National Registry. Am J Med 129(11):1170–1177

    PubMed  Google Scholar 

  • Nakao A, Sakagami K, Nakata Y, Komazawa K, Amimoto T, Nakashima K et al (2000) Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. J Gastroenterol 35:557–562

    CAS  PubMed  Google Scholar 

  • Nascimento AD, de Lima E, Boёchat G, Meyrelles S, Bissoli N, Lenz D, Endringer D, de Andrade T (2015) Testosterone induces apoptosis in cardiomyocytes by increasing proapoptotic signaling involving tumor necrosis factor-α and renin angiotensin system. Hum Exp Toxicol 34(11):1139–1147

    PubMed  Google Scholar 

  • Nielsen TL, Hagen C, Wraae K, Bathum L, Larsen R, Brixen K et al (2010) The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20–29-year-old Danish men: Odense androgen study. Eur J Endocrinol 162:795–804

    CAS  PubMed  Google Scholar 

  • Nieschlag E, Nieschlag S (2019) Endocrine history: the history of discovery, synthesis and development of testosterone for clinical use. Eur J Endocrinol 180:R201–R212

    CAS  PubMed  Google Scholar 

  • Nieschlag E, Vorona E (2015) Mechanisms in endocrinology: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol 173(2):47–58

    Google Scholar 

  • Nygren U, Södersten M, Falhammar H, Thorén M, Hagenfeldt K, Nordenskjöld A (2009) Voice characteristics in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol 70:18–25

    Google Scholar 

  • O'Sullivan AJ, Kennedy MC, Casey JH, Day RO, Corrigan B, Wodak AD (2000) Anabolic-androgenic steroids: medical assessment of present, past and potential users. Med J Aust 173:323–327

    CAS  PubMed  Google Scholar 

  • Parkinson AB, Evans NA (2006) Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc 38:644–651

    CAS  PubMed  Google Scholar 

  • Piacentino D, Kotzalidis GD, Del Casale A, Aromatario MR, Pomara C, Girardi P et al (2015) Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol 13:101–121

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pomara C, Neri M, Bello S, Fiore C, Riezzo I, Turillazzi E (2015) Neurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: a review. Curr Neuropharmacol 13:132–145

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S (2014) Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev 35:341–375

    CAS  PubMed  Google Scholar 

  • Przkora R, Jeschke MG, Barrow RE, Suman OE, Meyer WJ, Finnerty CC et al (2005) Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann Surg 242:384–389

    PubMed  PubMed Central  Google Scholar 

  • Rahnema CD, Crosnoe LE, Kim ED (2015) Designer steroids—over-the-counter supplements and their androgenic component: a systematic review on an increasing problem. Andrology 2:150–155

    Google Scholar 

  • Raschka C, Chmiel C, Preiss R, Boos C (2013) Recreational athletes and doping—a survey in 11 gyms in the area of Frankfurt/Main. Münch Med Wschr 155(Suppl 2):41–43

    Google Scholar 

  • Rasmussen JJ, Selmer C, Østergren PB, Pedersen KB, Schou M, Gustafsson F, Faber J, Juul A, Kistorp C (2016) Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study. PLoS One 11(8):e0161208

    PubMed  PubMed Central  Google Scholar 

  • Rochira V, Zirilli L, Madeo B, Maffei L, Carani C (2009) Testosterone action on erythropoiesis does not require its aromatization to estrogen: insights from the testosterone and estrogen treatment of two aromatase-deficient men. J Steroid Biochem Mol Biol 113:189–194

    CAS  PubMed  Google Scholar 

  • Rolf C, Nieschlag E (1998) Potential adverse effects of long-term testosterone therapy. Bailliere Clin Endocrinol Metab 12:521–534

    CAS  Google Scholar 

  • Roşca AE, Vlădăreanu AM, Mititelu A, Popescu BO, Badiu C, Căruntu C, Voiculescu SE, Onisâi M, Gologan Ş, Mirica R, Zăgrean L (2021) Effects of exogenous androgens on platelet activity and their Thrombogenic potential in Supraphysiological administration: a literature review. J Clin Med 10(1):147

    PubMed  PubMed Central  Google Scholar 

  • Sakhri S, Gooren LJ (2007) Safety aspects of androgen treatment with 5α-dihydrotestosterone. Andrologia 39:216–222

    CAS  PubMed  Google Scholar 

  • Schänzer W, Thevis M (2012) Detection of illegal use of androgens and selective androgen receptor modulators. In: Nieschlag E, Behre HM (eds) Testosterone: action, deficiency, substitution. Cambridge University Press, Cambridge, pp 517–534

    Google Scholar 

  • Schwingel PA, Cotrim HP, Santos CR Jr, Santos AO, Andrade AR, Carruego MV et al (2015) Recreational anabolic-androgenic steroid use associated with liver injuries among Brazilian young men. Subst Use Misuse 50(11):1490–1498

    PubMed  Google Scholar 

  • Shahidi NT (2001) A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther 23:1355–1390

    CAS  PubMed  Google Scholar 

  • Shamloul RM, Aborayah AF, Hashad A, Abd-Allah F (2014) Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patient. BMJ Case Rep 2014:bcr2013203033

    PubMed  PubMed Central  Google Scholar 

  • Shankara-Narayana N, Yu C, Savkovic S, Desai R, Fennell C, Turner L, Jayadev V, Conway A, Kockx M, Ridley L, Kritharides L, Handelsman D (2020) Rate and extent of recovery from reproductive and cardiac dysfunction due to androgen abuse in men. J Clin Endocrinol Metab 105(6):dgz324

    PubMed  Google Scholar 

  • Shapiro J, Christiana J, Frishman W (1999) Testosterone and other anabolic steroids as cardiovascular drugs. Am J Ther 6:167–174

    CAS  PubMed  Google Scholar 

  • Skarberg K, Nyberg F, Engstrom I (2009) Multisubstance use as a feature of addiction to anabolic-androgenic steroids. Eur Addict Res 15:99–106

    PubMed  Google Scholar 

  • Socas L, Zumbado M, Pérez-Luzardo O, Ramos A, Pérez C, Hernández JR et al (2005) Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med 39:e27

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sondergaard EB, Thune JJ, Gustafsson F (2014) Characteristics and outcome of patients referred for management of advanced heart failure due to anabolic-androgenic steroid abuse. Scand Cardiovasc J 21:1–11

    Google Scholar 

  • Strahm E, Mullen JE, Garevik N, Ericsson M, Schuze JJ, Anders R et al (2015) Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UTG2B17 deletion polymorphism. Drug Test Anal 7(11–12):1063–1070

    CAS  PubMed  Google Scholar 

  • Strauss RH, Liggett MT, Lanese RR (1985) Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA 253:2871–2873

    CAS  PubMed  Google Scholar 

  • Striegel H, Simon P, Frisch S, Roecker K, Dietz K, Dickhuth HH, Ulrich R (2006) Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend 81:11–19

    PubMed  Google Scholar 

  • Sullivan ML, Martinez CM, Gennis P, Gallagher EJ (1998) The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41:1–15

    CAS  PubMed  Google Scholar 

  • Thevis M, Schänzer W, Geyer H, Thieme D, Grosse J, Rautenberg C, Flenker U, Beuck S, Thomas A, Holland R, Dvorak J (2013) Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts. Br J Sports Med 47:109–114

    PubMed  Google Scholar 

  • Toorians A, Thomassen M, Zweegman S, Magdeleyns E, Tans G, Gooren L, Rosing J (2003) Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 88:5723–5729

    CAS  PubMed  Google Scholar 

  • Turillazzi E, Perilli G, Di Paolo M, Neri M, Riezzo I, Fineschi V (2011) Side effects of AAS abuse: an overview. Mini Rev Med Chem 11:374–389

    CAS  PubMed  Google Scholar 

  • Urman B, Pride SM, Yuen BH (1991) Elevated serum testosterone, hirsutism, and virilism associated with combined androgen-estrogen hormone replacement therapy. Obstet Gynecol 77:595–598

    CAS  PubMed  Google Scholar 

  • Van Staa TP, Sprafka JM (2009) Study of adverse outcomes in women using testosterone therapy. Maturitas 62:76–80

    PubMed  Google Scholar 

  • Van Thuyne W, Van Eenoo P, Delbeke FT (2006) Nutritional supplements: prevalence of use and contamination with doping agents. Nutr Res Rev 19:147–158

    PubMed  Google Scholar 

  • Vanderschueren D, Sinnesael M, Gielen E, Claessens F, Boonen S (2012) Testosterone and bone. In: Nieschlag E, Behre HM (eds) Testosterone: action, deficiency, substitution. Cambridge University Press, Cambridge, pp 177–199

    Google Scholar 

  • Walker J, Adams B (2009) Cutaneous manifestations of anabolic–androgenic steroid use in athletes. Int J Dermatol 48:1044–1048

    PubMed  Google Scholar 

  • Wang C, Nieschlag ESwerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros J-J, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FCW (2008) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 15:507–514

    CAS  Google Scholar 

  • Winkler U (1996) Effects of androgens on haemostasis. Maturitas 24:147–155

    CAS  PubMed  Google Scholar 

  • Wollina U, Pabst F, Schönlebe J, Abdel-Naser MB, Konrad H, Gruner M, Haroske G, Klemm E, Schreiber G (2007) Side-effects of topical androgenic and anabolic substances and steroids. A short review. Acta Dermatovenerol Alp Pannonica Adriat 16(3):117–122

    CAS  PubMed  Google Scholar 

  • Youssef MY, Alqallaf A, Abdella N (2011) Anabolic androgenic steroid-induced cardiomyopathy, stroke and peripheral vascular disease. BMJ Case Rep 2011:bcr1220103650

    PubMed  PubMed Central  Google Scholar 

  • Yu JG, Bonnerud P, Eriksson A, Stål PS, Tegner Y, Malm C (2014) Effects of long-term supplementation of anabolic androgen steroids on human skeletal muscle. PLoS One 9:1–11

    Google Scholar 

  • Zhu AZ, Cox LS, Ahluwalia JS, Renner CC, Hatsukami DK, Benowitz NL et al (2015) Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males. Pharmacogenet Genomics 25:263–269

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zitzmann M, Nieschlag E (2007) Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab 92:3844–3853

    CAS  PubMed  Google Scholar 

  • Zitzmann M, Junker R, Kamischke A, Nieschlag E (2002) Contraceptive steroids influence the hemostatic activation state in healthy men. J Androl 23:503–511

    CAS  PubMed  Google Scholar 

  • Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R (2007) Sexual hormones in human skin. Horm Metab Res 39:85–95

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Clinic B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Münster, Münster, Germany

    Elena Vorona

  2. Center of Reproductive Medicine and Andrology, University Hospital Münster, Münster, Germany

    Eberhard Nieschlag

Authors
  1. Elena Vorona
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eberhard Nieschlag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elena Vorona .

Editor information

Editors and Affiliations

  1. Center for Reproductive Medicine and Andrology, University Hospital Münster, Münster, Germany

    Eberhard Nieschlag

  2. Center for Reproductive Medicine and Andrology, University Hospital Halle (Saale), Martin Luther University Halle-Wittenberg, Halle (Saale), Germany

    Hermann M. Behre

  3. Center for Reproductive Medicine and Andrology, University Hospital Münster, Münster, Germany

    Sabine Kliesch

  4. Center for Reproductive Medicine and Andrology, University Hospital Münster, Münster, Germany

    Susan Nieschlag

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vorona, E., Nieschlag, E. (2023). Abuse of Anabolic Androgenic Steroids (AAS) for Doping. In: Nieschlag, E., Behre, H.M., Kliesch, S., Nieschlag, S. (eds) Andrology. Springer, Cham. https://doi.org/10.1007/978-3-031-31574-9_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-31574-9_37

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-31573-2

  • Online ISBN: 978-3-031-31574-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation